Nurix Therapeutics, Inc. NRIX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s free cash flow?
- Nurix Therapeutics, Inc. (NRIX) reported free cash flow of -$72.96M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s free cash flow changed year-over-year?
- Nurix Therapeutics, Inc.'s free cash flow decreased by 13.0% year-over-year, from -$64.57M to -$72.96M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s free cash flow?
- Over 3 years (2021 to 2025), Nurix Therapeutics, Inc.'s free cash flow has grown at a 43.0% compound annual growth rate (CAGR), from -$90.03M to -$263.47M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.